Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves

dc.contributor.authorCarnicelli, Anthony P.
dc.contributor.authorDe Caterina, Raffaele
dc.contributor.authorHalperin, Jonathan L.
dc.contributor.authorRenda, Giulia
dc.contributor.authorRuff, Christian T.
dc.contributor.authorTrevisan, Marco
dc.contributor.authorNordio, Francesco
dc.date.accessioned2024-02-23T14:26:43Z
dc.date.available2024-02-23T14:26:43Z
dc.date.issued2017
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.description.sponsorshipDaiichi Sankyoen_US
dc.description.sponsorshipThe ENGAGE AF-TIMI 48 trial was supported by a research grant from Daiichi Sankyo to the Brigham and Women's Hospital. All analyses were conducted independently by the Thrombolysis In Myocardial Infarction (TIMI) Study Group, and all authors had full access to the data. The authors are fully responsible for the study design, data collection, analysis and interpretation of the data, and the writing of the manuscript. The sponsor played no role in the decision to submit the manuscript for publication.en_US
dc.identifier.doi10.1161/CIRCULATIONAHA.116.026714
dc.identifier.endpage1275en_US
dc.identifier.issn0009-7322
dc.identifier.issn1524-4539
dc.identifier.issue13en_US
dc.identifier.pmid28209729en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1273en_US
dc.identifier.urihttps://doi.org/10.1161/CIRCULATIONAHA.116.026714
dc.identifier.urihttps://hdl.handle.net/20.500.12452/14311
dc.identifier.volume135en_US
dc.identifier.wosWOS:000397387200020en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofCirculationen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnticoagulationen_US
dc.subjectAtrial Fibrillationen_US
dc.subjectBioprosthetic Valveen_US
dc.subjectEdoxabanen_US
dc.subjectWarfarinen_US
dc.titleEdoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valvesen_US
dc.typeLetteren_US

Dosyalar